Key statistics
As of last trade, Vericel Corp (VCEL:NMQ) traded at 41.25, 36.68% above the 52 week low of 30.18 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 41.26 |
---|---|
High | 41.50 |
Low | 40.85 |
Bid | 41.18 |
Offer | 41.33 |
Previous close | 41.06 |
Average volume | 356.03k |
---|---|
Shares outstanding | 49.03m |
Free float | 48.58m |
P/E (TTM) | 2,171.34 |
Market cap | 2.01bn USD |
EPS (TTM) | 0.0189 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 19:13 BST.
More ▼
Announcements
- Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
- Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
- Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
- Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
- Vericel Reports Second Quarter 2024 Financial Results
- Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
- Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
- Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
- Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
- Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
More ▼